Alx Oncology Holdings Inc (NASDAQ:ALXO) shares, rose in value on Friday, November 01, with the stock price up by 1.40% to the previous day’s close as strong demand from buyers drove the stock to $1.45.
Actively observing the price movement in the last trading, the stock closed the session at $1.43, falling within a range of $1.4 and $1.515. The value of beta (5-year monthly) was 1.002. Referring to stock’s 52-week performance, its high was $17.83, and the low was $1.34. On the whole, ALXO has fluctuated by -15.70% over the past month.
With the market capitalization of Alx Oncology Holdings Inc currently standing at about $76.37 million, investors are eagerly awaiting this quarter’s results, scheduled for on 2024-Nov-11.
Technical indicators serve as essential tools for traders, offering insights into market sentiment and potential price movements. We see that ALXO’s technical picture suggests that short-term indicators denote the stock is a 100% Sell on average. However, medium-term indicators have put the stock in the category of 100% Sell while long-term indicators on average have been pointing out that it is a 100% Sell.
The stock’s technical analysis shows that the price of ALXO currently trading nearly -3.99% and -21.84% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 37.69, while the 7-day volatility ratio is showing 8.51% which for the 30-day chart, stands at 8.11%. Furthermore, Alx Oncology Holdings Inc (ALXO)’s beta value is 1.04, and its average true range (ATR) is 0.14.
A comparison of Alx Oncology Holdings Inc (ALXO) with its peers suggests the former has fared considerably weaker in the market. ALXO showed an intraday change of 1.40% in last session, and over the past year, it shrunk by -79.97%%.
Data on historical trading for Alx Oncology Holdings Inc (NASDAQ:ALXO) indicates that the trading volumes over the past 10 days have averaged 0.91 and over the past 3 months, they’ve averaged 964.27K. According to company’s latest data on outstanding shares, there are 49.95 million shares outstanding.
Nearly 42.64% of Alx Oncology Holdings Inc’s shares belong to company insiders and institutional investors own 69.79% of the company’s shares. The data on short interest also indicates that stock shorts accounted for 9.59 million shares as on 2024-10-15, resulting in a short ratio of 19.5. According to the data, the short interest in Alx Oncology Holdings Inc (ALXO) stood at 3159.00 of shares outstanding as of 2024-10-15; the number of short shares registered in 2024-09-13 reached 9.99 million. The stock has fallen by -90.26% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the ALXO stock heading into the next quarter.
